We develop and manufacture a wide range of oral, injectable, topical and specialty formulations — guiding your product from concept through scale-up to commercial cGMP production.
API characterization, excipient compatibility and risk assessment.
Prototype formulation, optimization and robustness studies.
Pilot and validation batches with process optimization.
cGMP commercial manufacturing with in-house quality control and QA.
Expertise in developing both oncology and non-oncology generics using advanced manufacturing technologies and robust quality systems.
Value-added formulations designed for product differentiation, lifecycle management and improved patient outcomes.
Formulation strategies that enable existing molecules to address new therapeutic indications.
Development strategies that balance data needs with prudent human exposure, supporting efficient clinical progression.
